Invion (ASX:IVX) - Executive Chair & CEO, Thian Chew
Executive Chair & CEO, Thian Chew
Source: Thian Chew/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal
  • IVX and RMW Cho Group will co-develop the tumour regression treatment technology for use on cancer and related diseases
  • Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region
  • The ASX-lister is hoping to raise $3 million in extra cash through a share placement plan and has received commitments for a $12 million placement
  • IVX shares have come out of a trading halt and are down 11.1 per cent at 2.4 cents each

Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal.

The life-sciences company came out of a trading halt today to announce the fundraise, expanded development deal and new license and distribution agreement.

Specifically, IVX and RMW Cho Group will co-develop Photosoft technology, a tumour regression treatment, for use on cancer and related diseases.

Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region.

The ASX-lister already holds the exclusive Australia and New Zealand license rights to
Photosoft for certain conditions, while RMW is the technology licenser.

To help fund the new agreements, IVX has completed a $12 million placement to investors, issuing 545 million new shares at 2.2 cents each.

A free attaching option will be issued for every 2nd share subscribed for, with an issue price of 4 cents and an expiry date 18 months from the time of issue.

Additionally, the company will carry out a $3 million share purchase plan (SPP) for IVX shareholders, with new shares also priced at 2.2 cents each.

Placement shares are due to settle on November 19, while the SPP opens next Monday and closes on December 3.

After resuming trade on Tuesday, Invion shares were trading down 11.1 per cent at 2.4 cents each at 12:50 pm AEDT.

IVX by the numbers
More From The Market Online
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…